6,7-Difluoro-1,2,3,4-tetrahydroquinoline, 97%, 250mg

4-(2,4-dichlorobenzoyl)-8-methyl-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

1-(6-Amino-3,3-dimethylindolin-1-yl)ethanone, 95.0%, 25g

Ethyl isopropyl sulfone, 98%, 100g

2-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 98%, 1g

BENZYL (4-(DIMETHOXYMETHYL)PYRIMIDIN-2-YL)CARBAMATE, 95.0%, 2g

4-Methylimidazolidine-2-thione, 98+%, 1g

BENZYL 4-(METHOXY(METHYL)AMINO)-4-OXOBUTYLCARBAMATE, 95.0%, 1g

7-Amino-1,2,3,4-tetrahydroquinoline, 95.0%, 250mg

2,4-Dichloro-7-fluoroquinazoline, 95.0%, 10g

Plan PLi S100x/1.25 oil immersion infinity corrected IOS objective. Working distance 0.36 mm

2-[Bis(2-chloroethyl)amino]-1,3,2-oxazaphosphinan-2-one hydrate, 97.0%, 10g

Methyl 5-chlorofuro[2,3-c]pyridine-2-carboxylate, 95%, 100mg